GREEN JOHN B 4
4 · Dicerna Pharmaceuticals Inc · Filed Dec 11, 2019
Insider Transaction Report
Form 4
GREEN JOHN B
Interim CFO
Transactions
- Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-12-11−8,000→ 219,500 totalExercise: $5.45Exp: 2026-04-14→ Common Stock (8,000 underlying) - Exercise/Conversion
Common Stock
2019-12-11$5.45/sh+8,000$43,600→ 18,698 total
Footnotes (2)
- [F1]Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).
- [F2]The option vested 25% after the first year anniversary of the vesting start date of April 14, 2016 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the reporting person's continued employment with the issuer through the applicable vesting date.